(Q63835155)

English

A Multicenter, Open-label, RebiSmart™ Autoinjector Ease of Use Study

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

short name

Performs (English)

0 references

title

A Twelve-week, Phase IIIb, Open-label, Single-arm, Multicenter Trial to Evaluate Ease of Use of an Electronic Autoinjector (RebiSmart™) for Self-injection in Subjects With Relapsing Multiple Sclerosis (RMS) Treated With Rebif® 44mcg Subcutaneously (sc) Three Times a Week (Tiw) (English)

0 references

0 references

0 references

January 2010

0 references

end time

August 2010

0 references